Beam Therapeutics CEO John Evans' 2021 pay jumps 1,434% to $14M
Beam Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 22, 2022
Beam Therapeutics reported fiscal year 2021 executive compensation information on April 22, 2022.
In 2021, three executives at Beam Therapeutics received on average a compensation package of $7.8M, a 177% increase compared to previous year.
Average pay of disclosed executives at Beam Therapeutics
John Evans, Chief Executive Officer, received $14M in total, which increased by 1,434% compared to 2020. 53% of Evans' compensation, or $7.3M, was in option awards. Evans also received $422K in non-equity incentive plan, $590K in salary, $5.6M in stock awards, as well as $11K in other compensation.
Giuseppe Ciaramella, Chief Scientific Officer, received a compensation package of $5.5M, which decreased by 19% compared to previous year. 48% of the compensation package, or $2.6M, was in option awards.
Terry-Ann Burrell, Chief Financial Officer, earned $3.9M in 2021, a 476% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 22, 2022.